The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014

In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state hea...

Full description

Bibliographic Details
Main Authors: Katrina F. Trivers, Juan L. Rodriguez, Summer L. Cox, Barbara E. Crane, Debra Duquette
Format: Article
Language:English
Published: MDPI AG 2015-10-01
Series:Healthcare
Subjects:
Online Access:http://www.mdpi.com/2227-9032/3/4/948
id doaj-6a2aabd68aa64f1eab9e63cc0c981012
record_format Article
spelling doaj-6a2aabd68aa64f1eab9e63cc0c9810122020-11-24T23:06:00ZengMDPI AGHealthcare2227-90322015-10-013494896310.3390/healthcare3040948healthcare3040948The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014Katrina F. Trivers0Juan L. Rodriguez1Summer L. Cox2Barbara E. Crane3Debra Duquette4Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USADivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USAOregon Health Authority, Portland, OR 97232, USAGeorgia Department of Public Health, Atlanta, GA 30303-3142, USAMichigan Department of Health and Human Services, Lansing, MI 48909, USAIn 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state health departments to promote the application of best practices for evidence-based breast cancer genomics through education, surveillance, and policy activities. The FOA required that applicants focus on activities related to hereditary breast and ovarian cancer (HBOC). The DCPC funded three states: Georgia, Michigan, and Oregon. Georgia was a first-time recipient of cancer genomics funding, whereas Michigan and Oregon had long standing activities in cancer genomics and had received CDC funding in the past. By the end of the funding period, each state had well-functioning and impactful state-based programs in breast cancer genomics. This article highlights the impact of a few key state activities by using CDC’s Science Impact Framework. There were challenges to implementing public health genomics programs, including the need to develop relevant partnerships, the highly technical nature of the subject matter, a lack of genetic services in certain areas, and the difficulty in funding genetic services. Georgia, Michigan, and Oregon have served as models for others interested in initiating or expanding cancer genomics programs, and they helped to determine what works well for promoting and integrating public health genomics into existing systems.http://www.mdpi.com/2227-9032/3/4/948genomicsgenetic servicesimplementationstate health departmentsBRCAbreast cancerovarian cancerhereditary breastovarian cancer
collection DOAJ
language English
format Article
sources DOAJ
author Katrina F. Trivers
Juan L. Rodriguez
Summer L. Cox
Barbara E. Crane
Debra Duquette
spellingShingle Katrina F. Trivers
Juan L. Rodriguez
Summer L. Cox
Barbara E. Crane
Debra Duquette
The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
Healthcare
genomics
genetic services
implementation
state health departments
BRCA
breast cancer
ovarian cancer
hereditary breast
ovarian cancer
author_facet Katrina F. Trivers
Juan L. Rodriguez
Summer L. Cox
Barbara E. Crane
Debra Duquette
author_sort Katrina F. Trivers
title The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
title_short The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
title_full The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
title_fullStr The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
title_full_unstemmed The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014
title_sort activities and impact of state programs to address hereditary breast and ovarian cancer, 2011–2014
publisher MDPI AG
series Healthcare
issn 2227-9032
publishDate 2015-10-01
description In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state health departments to promote the application of best practices for evidence-based breast cancer genomics through education, surveillance, and policy activities. The FOA required that applicants focus on activities related to hereditary breast and ovarian cancer (HBOC). The DCPC funded three states: Georgia, Michigan, and Oregon. Georgia was a first-time recipient of cancer genomics funding, whereas Michigan and Oregon had long standing activities in cancer genomics and had received CDC funding in the past. By the end of the funding period, each state had well-functioning and impactful state-based programs in breast cancer genomics. This article highlights the impact of a few key state activities by using CDC’s Science Impact Framework. There were challenges to implementing public health genomics programs, including the need to develop relevant partnerships, the highly technical nature of the subject matter, a lack of genetic services in certain areas, and the difficulty in funding genetic services. Georgia, Michigan, and Oregon have served as models for others interested in initiating or expanding cancer genomics programs, and they helped to determine what works well for promoting and integrating public health genomics into existing systems.
topic genomics
genetic services
implementation
state health departments
BRCA
breast cancer
ovarian cancer
hereditary breast
ovarian cancer
url http://www.mdpi.com/2227-9032/3/4/948
work_keys_str_mv AT katrinaftrivers theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT juanlrodriguez theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT summerlcox theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT barbaraecrane theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT debraduquette theactivitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT katrinaftrivers activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT juanlrodriguez activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT summerlcox activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT barbaraecrane activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
AT debraduquette activitiesandimpactofstateprogramstoaddresshereditarybreastandovariancancer20112014
_version_ 1725624387273490432